申请人:Imperial Chemical Industries
公开号:US04544662A1
公开(公告)日:1985-10-01
The invention provides novel spiro[oxazolidine-5,3'-indoline]-2,2',4-triones of formula I bearing substituted benzyl or cinnamyl on the indoline nitrogen, together with salts and non-toxic, biodegradable precursors thereof. The compounds are potent inhibitors of the enzyme aldose reductase and are useful in treating or preventing certain diabetic complications. The invention also provides pharmaceutical compositions containing, and processes for the manufacture of, the compounds of formula I and their salts and derivatives.
本发明提供了一种新型的spiro[oxazolidine-5,3'-indoline]-2,2',4-triones化合物,其化学式为I,其在indoline氮原子上带有取代苯基或肉桂基,以及其盐和无毒、可生物降解的前体。这些化合物是醛糖还原酶酶的有效抑制剂,可用于治疗或预防某些糖尿病并发症。本发明还提供了含有该化合物及其盐和衍生物的制药组合物和制备该化合物及其盐和衍生物的方法。